Cargando…
Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review
The prevalence of obesity and diabetes is an increasing global problem, especially in developed countries, and is referred to as the twin epidemics. As such, advanced treatment approaches are needed. Tirzepatide, known as a ‘twincretin’, is a ‘first-in-class’ and the only dual glucagon-like peptide-...
Autores principales: | Chavda, Vivek P., Ajabiya, Jinal, Teli, Divya, Bojarska, Joanna, Apostolopoulos, Vasso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268041/ https://www.ncbi.nlm.nih.gov/pubmed/35807558 http://dx.doi.org/10.3390/molecules27134315 |
Ejemplares similares
-
Antibody–Biopolymer Conjugates in Oncology: A Review
por: Chavda, Vivek P., et al.
Publicado: (2023) -
Peptide-Drug Conjugates: A New Hope for Cancer Management
por: Chavda, Vivek P., et al.
Publicado: (2022) -
Advent of tirzepatide: boon for diabetic and obese?
por: Bhusal, Amrit
Publicado: (2023) -
mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics
por: Chavda, Vivek P., et al.
Publicado: (2022) -
Omicron variant (B.1.1.529) of SARS-CoV-2: Threat for the elderly?
por: Chavda, Vivek P, et al.
Publicado: (2022)